Last update 25 Mar 2025

Trastuzumab biosimilar(Shanghai Henlius Biotech, Inc.)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
Trastuzumab Biosimilar (Shanghai Henlius Biotech, Inc.), TRASTUZUMAB-STRF, 曲妥珠单抗生物类似药(Shanghai Henlius Biotech, Inc.)
+ [9]
Target
Action
antagonists
Mechanism
HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Early Stage Breast Carcinoma
Canada
22 Aug 2024
Metastatic breast cancer
Canada
22 Aug 2024
HER2 positive Gastrooesophageal junction cancer
Australia
18 Jul 2022
HER2-positive gastric cancer
China
12 Aug 2020
HER2 Positive Breast Cancer
European Union
27 Jul 2020
HER2 Positive Breast Cancer
Iceland
27 Jul 2020
HER2 Positive Breast Cancer
Liechtenstein
27 Jul 2020
HER2 Positive Breast Cancer
Norway
27 Jul 2020
HER2 positive Gastroesophageal Junction Adenocarcinoma
European Union
27 Jul 2020
HER2 positive Gastroesophageal Junction Adenocarcinoma
Iceland
27 Jul 2020
HER2 positive Gastroesophageal Junction Adenocarcinoma
Liechtenstein
27 Jul 2020
HER2 positive Gastroesophageal Junction Adenocarcinoma
Norway
27 Jul 2020
HER2 Positive Stomach Adenocarcinoma
European Union
27 Jul 2020
HER2 Positive Stomach Adenocarcinoma
Iceland
27 Jul 2020
HER2 Positive Stomach Adenocarcinoma
Liechtenstein
27 Jul 2020
HER2 Positive Stomach Adenocarcinoma
Norway
27 Jul 2020
Hormone receptor positive breast cancer
European Union
27 Jul 2020
Hormone receptor positive breast cancer
Iceland
27 Jul 2020
Hormone receptor positive breast cancer
Liechtenstein
27 Jul 2020
Hormone receptor positive breast cancer
Norway
27 Jul 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 3
China
11 Nov 2016
Breast CancerPhase 3
Philippines
11 Nov 2016
Breast CancerPhase 3
Ukraine
11 Nov 2016
NeoplasmsPhase 1
China
04 Mar 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
nhmnpsxyha(zmnovrhqtg) = krpbibsexs dogmnwmglt (vyuoelpyie, 11.5 - 12.1)
Positive
25 Feb 2025
欧洲市售曲妥珠单抗联合多西他赛
nhmnpsxyha(zmnovrhqtg) = eqcnrvfjjw dogmnwmglt (vyuoelpyie, 9.5 - 11.7)
Phase 3
652
(HLX02+Docetaxel)
chtodsepff = hrbmadlvlu egugyxxaoo (xwxhnlvdkt, ibegumlivb - jbphqcvrww)
-
17 May 2024
Herceptin®+docetaxel
(Herceptin®+Docetaxel)
chtodsepff = vmoehcxpgv egugyxxaoo (xwxhnlvdkt, iqahkquvwk - ikmmspnyjr)
FDA_CDER
ManualManual
Not Applicable
HER2 Positive Breast Cancer
ERBB2 Amplification | HER2 Overexpression
3,386
Chemo → Trastuzumab
(one-year trastuzumab treatment)
mhjbmfbwuo(jrdnikgslf) = xibclwkpew uxqnjdeohg (iarvunmhft )
Positive
25 Apr 2024
FDA_CDER
ManualManual
Not Applicable
222
kkqrzepxmf(aelberglyr) = mnmjsgckod qxxpdpcupf (cwudtqnasi )
Positive
25 Apr 2024
FDA_CDER
ManualManual
Not Applicable
HER2 Positive Breast Cancer
HER2 Expression | ERBB2 Amplification
4,063
AC → TH(doxorubicin and cyclophosphamide followed by paclitaxel plus trastuzumab)
jmgqiwznii(qnulwqxkjd) = reoabvvzhk gmhxfucefn (kerznapghe )
Positive
25 Apr 2024
AC → T(doxorubicin and cyclophosphamide followed by paclitaxel)
jmgqiwznii(qnulwqxkjd) = crrlfrhmbt gmhxfucefn (kerznapghe )
FDA_CDER
ManualManual
Not Applicable
-
Trastuzumab + All Chemotherapy
shwucnjjol(xnkqdgorsu) = rizjeprtsk aggvkxnjdy (joikbivxzn, 7 - 8)
Positive
25 Apr 2024
All Chemotherapy
shwucnjjol(xnkqdgorsu) = wxwzvylzar aggvkxnjdy (joikbivxzn, 4 - 5)
FDA_CDER
ManualManual
Not Applicable
594
Trastuzumab in combination with cisplatin and a fluoropyrimidine (FC+H)
ffzhoshlee(wkjbumqfzl) = sdbpsalctb jdfoyecftb (mlveqcyzri, 11.7 - 15.7)
Positive
25 Apr 2024
Chemotherapy alone (FC)
ffzhoshlee(wkjbumqfzl) = dtyoujupmp jdfoyecftb (mlveqcyzri, 9.4 - 12.5)
Phase 3
649
yqpkmfpxcy(shfellafia) = tkcodozyth yrsvjvuuae (coertrfemq )
Similar
19 Jul 2022
yqpkmfpxcy(shfellafia) = ekxmuvkuff yrsvjvuuae (coertrfemq )
Phase 1
-
123
farvudeplp(obrcobfkwp): GLSMR = 0.95 (90% CI, 0.891 - 1.013)
-
01 Mar 2021
CN-trastuzumab
Phase 3
649
oeldncwrno(bhrxakjoti) = tksqkrotgf yewjlsjhbx (axbpbaksqb )
Positive
19 Sep 2020
EU-TZB
oeldncwrno(bhrxakjoti) = rgneuorgpf yewjlsjhbx (axbpbaksqb )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free